• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Hester Biosciences Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 4164.0
  • ISIN : INE782E01017
1,805.00 11 (0.59%)
  • As on 11 Jul 2025 (EOD)

  • Today’s Low

    1,800.00

  • Today’s High

    1,830.00

  • Open

    1,809.10

  • Perv Close

    1,794.50

  • 52W Low

    1,242.95

  • 52W High

    3,379.00

Key Indicators

  • P/E(TTM)

    48.29

  • Mar.Cap (₹Cr.)

    1,535.49

  • Div & Yield %

    0.39

  • Book Value(₹)

    398.60

  • Debt-Equity Ratio

    0.59

  • AGM Date

    11-Jul-2025

  • EPS

    37.43

  • P/E Ratio

    48.29

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    1,535.49

  • RONW (%)

    7.41

  • ROCE (%)

    8.74

Score Board

  • Equity (₹ in Cr.)

    8.51

  • BV (₹)

    398.60

  • Sales( ₹ in Cr.)

    286.47

  • NP (in Cr.)

    31.84

  • NP Var(%)

    17.0

  • Div%

    70.0

  • CPS (₹)

    47.50

  • EPS (₹)

    37.40

  • Traded Value (₹ in Lakhs)

    1,537.66

  • 52 Week High

    3,379.00

  • 52 Week Low

    1,242.95

  • Price BSE

    1808.0

  • Price NSE

    1,805.00

  • Market Capital( in Cr.)

    1,537.66

  • P/C Ratio

    38.00

  • P/E Ratio

    48.30

  • Price Vs.BV

    37.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 285.16 254.00 219.35 208.48 169.43 171.19
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 285.16 254.00 219.35 208.48 169.43 171.19
Other Income 4.26 5.32 4.66 1.65 2.93 3.10
Stock Adjustments -10.36 4.77 12.53 -4.01 15.57 7.25
Total Income 279.06 264.09 236.54 206.12 187.93 181.54
EXPENDITURE :            
Raw Materials 89.28 84.65 76.37 49.38 44.81 41.88
Power and Fuel Cost 12.34 9.95 8.74 6.93 7.29 7.08
Employee Cost 56.72 47.92 39.12 33.45 37.16 26.74
Other Manufacturing Expenses 12.00 7.57 6.89 5.46 6.19 10.48
Selling and Administration Expenses 52.74 49.26 34.94 32.24 32.88 22.83
Miscellaneous Expenses 4.37 4.55 5.26 10.28 3.95 1.65
Employee Benefit Expenses 56.72 47.92 39.12 33.45 37.16 26.74
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 227.45 203.88 171.31 137.74 132.28 110.66
Operating Profit 51.60 60.21 65.23 68.37 55.64 70.86
Interest 5.09 6.50 2.47 3.95 5.03 3.54
Gross Profit 46.51 53.71 62.76 64.42 50.61 67.32
Depreciation 9.78 9.79 9.50 9.63 9.39 7.57
Profit Before Tax 36.73 43.92 53.26 54.79 41.22 59.75
Current Tax 9.64 10.73 14.25 16.37 11.81 15.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.06 0.86 -0.51 -1.48 -1.80 0.66
Reported Net Profit 27.16 32.34 39.52 39.90 31.22 43.85
Extraordinary Items 0.02 0.01 0.09 -3.69 0.38 -0.04
Adjusted Net Profit 27.14 32.33 39.43 43.59 30.84 43.89
Adjustment below Net Profit -0.02 0.11 -0.16 0.21 -1.63 -10.49
P & L Balance brought forward 226.20 202.25 171.40 136.90 113.25 79.90
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 6.81 8.51 8.51 5.62 5.96 0.00
P & L Balance carried down 246.53 226.20 202.25 171.40 136.90 113.25
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 60.00 80.00 100.00 100.00 66.00 110.00
Dividend Per Share(Rs) 6.00 8.00 10.00 10.00 6.60 11.00
Earnings Per Share-Unit Curr 31.93 38.02 46.45 46.90 36.70 51.55
Earnings Per Share(Adj)-Unit Curr 31.93 38.02 46.45 46.90 36.70 51.55
Book Value 367.59 343.70 315.54 279.28 238.72 210.93
Book Value(Adj)-Unit Curr 367.59 343.70 315.54 279.28 238.72 210.93

Shareholding Pattern

  • Promoter Group

    53.73%

  • Public Share Holding

    46.27%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 803,955 803,955.00 803,955 803,955
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 803,955 9.45 803,955 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 336,838 3.96 336,838 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,430,151 40.32 3,430,151 8
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 3,766,989 44.28 3,766,989 11
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,700 0.04 3,700 3
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 40,289 0.47 40,289 15
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 151 0.00 151 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,500 0.02 1,500 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 45,640 0.54 45,640 21
2] Non Institution
Bodies Corporate 266,005 3.13 266,004 120
Clearing Members 14 0.00 14 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 517,902 6.09 517,902 387
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 216,804 2.55 216,704 345
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,237,827 14.55 1,237,827 16
Individuals holding nominal share capital up to Rs. 1 lakh 1,552,320 18.25 1,487,753 10,889
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 2,649 0.03 2,649 2
Others 83,652 0.98 83,652 1
Sub Total 3,890,281 45.73 3,825,613 11,776
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,506,865 100.00 8,442,197 11,810

Company Background

Hester Biosciences LtdPharmaceuticals - Indian - Formulations

  • Hester Biosciences Ltd
  • BSE Code : 4164.0
  • ISIN : INE782E01017

  • Incorporation Year

    1987

  • Registered Office

    1st Flr PushpakPachvati Circle
    Motilal Hirabhai Road, Ahmedabad,
    Gujarat-380006

  • Telephone

    91-079-26445107

  • FAX

    91-079-26445105

  • Chairman

    Bhupendra V Gandhi

  • Managing Director

    Rajiv D Gandhi

  • Company Secretary

  • Auditor

    Chandulal M Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Hester Biosciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Hester Bios 1,807.55 289.42 285.16 48.29 8.51
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10